Novavax Inc (NVAX)

$12.97 0.00 (0.00%)

16:00 EDT NVAX Stock Quote Delayed 30 Minutes

Exit Now! 3 Biotech Stocks to Sell in February 2024

By Muslim Farooque, InvestorPlace Contributor Feb 21, 2024

These biotech stocks to sell represent incredibly risky bets, amidst the sector's volatility and looming economic unpredictability.

Get Rich Quick With These 3 Stocks to Buy Now

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024

Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts

Volume:

Previous Close -

Market Cap 966.06M

PE Ratio -4.05

EPS -3.2

Volume (Avg. Vol.) 2,974

Day's Range -

52-Week Range $3.53 - $23.86

Dividend & Yield N/A (N/A)

NVAX Stock Predictions, Articles, and Novavax Inc News

Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold

By Faisal Humayun, InvestorPlace Contributor Jan 15, 2024

Be sure to sell these meme stocks as they represent fundamentally weak businesses that will continue to erode in value.

Time to Buy These 3 Stocks That Just Hit a 52-Week Low?

By Rich Duprey, InvestorPlace Contributor Jan 15, 2024

Sometimes buying stocks at a 52-week low is a chance to buy a good company at great prices but you need to see if the business is busted.

Smart Shorts: 7 Meme Stocks to Bet Against in 2024

By Thomas Niel, InvestorPlace Contributor Dec 28, 2023

These seven meme stocks have surged as speculators declare "the coast is clear," but a big reversal for each of them may be forthcoming.

3 Heavily Shorted Stocks That Still Won’t See a Squeeze

By Faisal Humayun, InvestorPlace Contributor Dec 25, 2023

These are the heavily shorted stocks to avoid as they are likely to continue trending lower on the back of very weak fundamentals.

3 Meme Stocks That Could Fade Away in 2024

By Faisal Humayun, InvestorPlace Contributor Dec 18, 2023

These are the meme stocks to avoid or sell as they have extremely weak fundamentals and are unlikely to recover from a financial perspective.

3 Short-Squeeze Stocks That Could Take Off Before Year-End

By Shane Neagle, InvestorPlace Contributor Nov 30, 2023

These three short-squeeze stocks are seeing high short interest. They each could see a year-end short squeeze and notable market moves.

7 Dangerous Stocks to Avoid No Matter What

By Thomas Niel, InvestorPlace Contributor Nov 1, 2023

Despite arguments to the contrary, stay away from each of these seven stocks to avoid, as each carries substantial downside risk.

Novavax (NVAX) Stock Slides Despite Vaccine Availability

By Josh Enomoto, InvestorPlace Contributor Oct 13, 2023

Although Novavax’s non-mRNA vaccine being available broadly represents good news, NVAX stock suffered due to unfavorable timing.

3 Pharma Stocks to Dump Before the Damage Is Done

By Alex Sirois, InvestorPlace Contributor Oct 8, 2023

There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears.

Short Sellers Are Betting Against Novavax (NVAX) Stock

By Dana Blankenhorn, InvestorPlace Contributor Oct 4, 2023

Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.

NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month

By Josh Enomoto, InvestorPlace Contributor Sep 28, 2023

With the market suffering losses due to broader headwinds, hedge funds have targeted the most shorted stocks for cynical profits.

Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done

By Chandler Capital, InvestorPlace Contributor Sep 26, 2023

Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks.

7 Biotech Stocks to Sell in September Before They Crash & Burn

By Alex Sirois, InvestorPlace Contributor Sep 6, 2023

Biotech stocks to sell are a dime a dozen and very risky which is why September is a great time to offload them.

7 Undervalued Stocks Due for a Massive Short Squeeze

By Faisal Humayun, InvestorPlace Contributor Sep 1, 2023

These are the undervalued short squeeze candidates that are poised for multibagger returns

3 Biotech Stocks Due for a Massive Short Squeeze

By Faisal Humayun, InvestorPlace Contributor Aug 31, 2023

These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters.

3 of Wall Street’s Most Shorted Stocks Due for a Massive Short Squeeze

By Tyrik Torres, InvestorPlace Contributor Aug 30, 2023

These are the most shorted stocks trading in the U.S. stock market, and any good news could put their short sellers into a serious bind.

7 Very Oversold Nasdaq Stocks to Buy Right Now

By Larry Ramer, InvestorPlace Contributor Aug 23, 2023

The worries that have pushed the Nasdaq down sharply are overdone. Here are seven oversold Nasdaq stocks poised to rebound.

Novavax (NVAX) Stock Is Getting Ready to Rally Again

By Dana Blankenhorn, InvestorPlace Contributor Aug 22, 2023

Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot.

Why Is Novavax (NVAX) Stock Up 15% Today?

By Chris MacDonald, InvestorPlace Contributor Aug 21, 2023

Investors in Novavax have had a very rough go over the past two years, but NVAX stock is rebounding nicely today.

3 Biotech Stocks to Sell in August Before They Crash and Burn

By Alex Sirois, InvestorPlace Contributor Aug 14, 2023

These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late.

Novavax Inc (NVAX)

Exit Now! 3 Biotech Stocks to Sell in February 2024

Get Rich Quick With These 3 Stocks to Buy Now

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024

Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novavax Inc (NVAX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVAX Stock Predictions, Articles, and Novavax Inc News

Subscriber Sign in